ReNeuron Group (AIM: RENE)

Last close As at 24/05/2024

3.38

0.00 (0.00%)

Market capitalisation

2m

ReNeuron is a UK biotech company developing allogeneic cell therapies. The first pivotal Phase IIb trial for CTX neural stem cells for chronic stroke disability is underway. Human retinal progenitor cells (hRPCs) are also being studied for RP (in Phase I/IIa).

Latest Insights

View More
ReNeuron-Group_resized

Sector

Healthcare

Balance Sheet

Forecast net debt (£m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 0.0 (20.6) (69.3)
Relative (0.6) (22.5) (68.1)
52 week high/low 10.8p/3.4p

Financials

Edison Investment Research is terminating coverage on ReNeuron Group (RENE). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Y/E Mar Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2022A 0.4 N/A (11.1) (17.01) N/A N/A
2023A 0.5 N/A (6.7) (9.47) N/A N/A
2024E N/A N/A N/A N/A N/A N/A
2025E N/A N/A N/A N/A N/A N/A

Update

Healthcare

ReNeuron Group — Stable 12-month vision

Update

Healthcare

ReNeuron Group — Zero overhang

Outlook

Healthcare

ReNeuron Group — A transformational year

Flash note

Healthcare

ReNeuron Group — Formative event

Flash note

Healthcare

ReNeuron Group — Open season on Exosome deals

Outlook

Healthcare

ReNeuron Group — Time to reflect

Flash note

Healthcare

ReNeuron Group — Exosomes rise further

Update

Healthcare

ReNeuron Group — The rise of the exosome

Update

Healthcare

ReNeuron Group — Consolidation confusion?

Update

Healthcare

ReNeuron Group — Biblical aspirations

edison tv

Healthcare

Executive Interview – ReNeuron

Update

Healthcare

ReNeuron Group — Update 7 December 2016

Update

Healthcare

ReNeuron Group — Update 5 August 2016

Outlook

Healthcare

ReNeuron Group — Update 27 July 2016

edison tv

Healthcare

Executive Interview – ReNeuron

Update

Healthcare

ReNeuron — Update 24 March 2016

edison tv

Healthcare

Executive Interview – ReNeuron